Vagus Nerve Stimulation Shows Promise in Treating Drug-Resistant Epilepsy

Strategic Insights -

Researchers from the Uniformed Services University of the Health Sciences have conducted a study to identify predictors of response to vagus nerve stimulation (VNS) in patients with drug-resistant epilepsy (DRE). The study, published in Neurosurgical Review, found that individuals with generalized epilepsy demonstrated significantly higher responder rates compared to those with focal or combined epilepsy. The overall responder rate was 35.8%, with 86% of those with generalized epilepsy showing a positive response to VNS.

Key Takeaways:

  • The study found that individuals with generalized epilepsy had a significantly higher responder rate to VNS compared to those with focal or combined epilepsy, with 86% of those with generalized epilepsy showing a positive response.
  • The overall responder rate was 35.8%, indicating that VNS is a potentially effective treatment for DRE.
  • The study's authors emphasized the need for future long-term, randomized controlled trials with larger cohorts to better evaluate the association between VNS outcomes and critical variables.
  • The research concluded that identifying predictors of response to VNS is essential for optimizing treatment outcomes and improving patient care.
  • The study highlights the importance of VNS as an adjunctive therapy for patients with DRE who have not responded to medication.

Statistics:

  • Overall responder rate to VNS: 35.8%
  • Responder rate for individuals with generalized epilepsy: 86%
  • Responder rate for individuals with focal epilepsy: 29%
  • Responder rate for individuals with combined epilepsy: 28%
  • Duration of epilepsy correlated with response to VNS: shorter duration of epilepsy was associated with better response rates.

Sources:

  • Neurosurgical Review, "Outcome and predictors of response to vagus nerve stimulation for drug-resistant epilepsy: a retrospective cohort study," Neurosurgical Review, 2025;48(1):676.
  • Uniformed Services University of the Health Sciences, "Vagus Nerve Stimulation for Drug-Resistant Epilepsy," Bethesda, MD, United States.
  • Springer, "Neurosurgical Review," One New York Plaza, Suite 4600, New York, NY, United States.